Published

Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The Australian and New Zealand journal of psychiatry
Date: 2023-07-01
Source: PubMed
DOI: 10.1177/00048674231172691
PubMed: 37139585

Authors

Rossell SL Meikle SE Williams ML Castle DJ

Watch author

Derived topics and classifications

psilocybin Depression Healthcare Workers Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?2023-07-01

Related papers

Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers.The Australian and New Zealand journal of psychiatry · 2025-09-01 Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.The Australian and New Zealand journal of psychiatry · 2026-07-01 Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.The Medical journal of Australia · 2017-06-19 A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.ClinicalTrials.gov · 2026-03-03 Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01 A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.The Australian and New Zealand journal of psychiatry · 2024-07-01 The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.The Australian and New Zealand journal of psychiatry · 2023-07-01 Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.The Australian and New Zealand journal of psychiatry · 2021-12-01